Share:

Other, containing antimalarial active principles described in subheading note 2 to this chapter

Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: > Other, containing antimalarial active principles described in subheading note 2 to this chapter

Duty Rate (from China)

0%
MFN Base RateFree

Articles the product of any country, as provided for in subdivision (aa)(ii) of U.S. note 2 to this subchapter

Total Effective Rate0%

Products classified under HTS 3004.60.00.00

Artemether-Lumefantrine Tablets

Combination tablets containing artemether and lumefantrine, both antimalarial active principles listed in subheading note 2, put up in measured doses for retail sale. Classified under HTS 3004.60.00.00 as a mixed product for therapeutic use against Plasmodium falciparum malaria. Each pack provides a full adult treatment course.

Chloroquine Phosphate Tablets 250mg

Tablets containing chloroquine phosphate, a synthetic antimalarial quinine derivative per subheading note 2, dosed at 250mg for prophylactic or treatment use. Put up in blister packs for retail sale under HTS 3004.60.00.00. Used primarily for Plasmodium vivax suppression.

Atovaquone-Proguanil Hydrochloride Tablets

Malarone-brand equivalent tablets combining atovaquone and proguanil HCl, both note 2 antimalarials, in 250mg/100mg doses for malaria prophylaxis. Retail-packed in measured doses per HTS 3004.60.00.00 as mixed therapeutic product. Suitable for travelers to endemic areas.

Primaquine Phosphate Tablets 15mg

Tablets of primaquine phosphate 15mg, an 8-aminoquinoline antimalarial from subheading note 2, used for radical cure of P. vivax relapse prevention. Dispensed in measured doses for retail under HTS 3004.60.00.00. Requires G6PD testing prior to use.

Quinine Sulfate Capsules 300mg

Capsules containing quinine sulfate 300mg, the canonical antimalarial alkaloid per subheading note 2, for severe falciparum treatment. Put up in measured doses for retail sale under HTS 3004.60.00.00. Also used for nocturnal leg cramps off-label.

Mefloquine Hydrochloride Tablets 250mg

Lariam-equivalent mefloquine HCl 250mg tablets, synthetic 4-quinoline methanol antimalarial listed in note 2, for weekly prophylaxis. Retail blister packs in measured doses per HTS 3004.60.00.00. Not recommended for neuropsychiatric risks.

Sulfadoxine-Pyrimethamine Tablets

Fansidar tablets combining sulfadoxine 500mg and pyrimethamine 25mg, both note 2 antimalarials, for intermittent preventive treatment. Measured doses in retail packs under HTS 3004.60.00.00. Used in pregnancy for placental malaria protection.

Doxycycline Hyclate 100mg Capsules

Doxycycline hyclate 100mg capsules, tetracycline antimalarial per subheading note 2, used in combination therapy for multidrug-resistant strains. Retail-measured doses under HTS 3004.60.00.00. Photosensitivity warnings required.

Artesunate 50mg Injection Vials

Lyophilized artesunate 60mg (as 50mg base) powder for injection, artemisinin derivative antimalarial of note 2, for severe malaria IV use. Single-dose vials for retail/therapeutic under HTS 3004.60.00.00. Reconstituted with sodium bicarbonate.

Pyrimethamine 25mg Tablets

Pyrimethamine 25mg tablets, antifolate antimalarial agent per note 2, used with sulfa for toxoplasmosis and malaria. Measured retail doses under HTS 3004.60.00.00. Often combined but available unmixed.